Related Experiment Video
Updated: Jul 6, 2026

09:52
An Implantable System For Chronic In Vivo Electromyography
Published on: April 21, 2020
Vocal cord abductor paralysis in multiple system atrophy: a case report
Naoya Egami1, Aki Inoue, Ryuichi Osanai
1Department of Otolaryngology, Showa General Hospital, 2-450 Tenjin-chou, Kodaira-shi, Tokyo, Japan. n-egami@s7.dion.ne.jp
Acta Oto-Laryngologica. Supplementum
|April 12, 2008
Summary
Multiple system atrophy (MSA) can cause vocal cord abductor paralysis (VCAP), a serious complication leading to sleep apnea. Early VCAP detection aids in diagnosing MSA and preventing sudden death.
Area of Science:
- Neurology
- Neurodegenerative Diseases
- Sleep Medicine
Background:
- Multiple system atrophy (MSA) is a progressive neurodegenerative disorder affecting motor control, autonomic function, and coordination.
- Vocal cord abductor paralysis (VCAP) is a critical complication of MSA, often indicating a poor prognosis and risk of sudden nocturnal death.
Observation:
- A case report details a patient initially treated for Parkinson's disease presenting with dizziness and sleep apnea.
- Fiberoptic laryngoscopy identified VCAP as a potential cause of the patient's sleep apnea.
- The patient exhibited severely impaired optokinetic nystagmus and absent caloric test responses, indicative of neuro-otological dysfunction.
Findings:
- VCAP, typically seen in advanced MSA stages, was identified in this patient potentially earlier than usual.
- Abnormal neuro-otological findings, including VCAP, were crucial in diagnosing MSA.
Implications:
- This case highlights the importance of considering VCAP in patients with unexplained sleep apnea, especially those with parkinsonian symptoms.
- Early diagnosis of MSA through objective findings like VCAP can lead to timely management and potentially improve patient outcomes.
- Recognizing VCAP as an early sign in MSA may facilitate earlier intervention and management strategies for this debilitating disease.
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...